BridgeMD
Compares treatment options for Miscarriage in First Trimester
Official title Letrozole Plus Misoprostol Versus Misoprostol Alone for Treating Women With Missed Miscarriage
ClinicalTrials.gov ID: NCT07160855
What this study is testing
What is Misoprostol (given vaginally)?
Misoprostol (given vaginally) is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for miscarriage in first trimester.
Also referred to as Cytotec, Arthrotec.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn whether adding the medicine letrozole to Misoprostol helps women have a complete abortion more often than using Misoprostol alone for the treatment of missed miscarriage (when a pregnancy has stopped developing but has not yet passed naturally). The main questions this study aims to answer are: 1.
- Phase 4: studies an already-approved treatment
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Pregnant women up till 13th weeks of gestation according to last menstrual period (LMP) dates, confirmed on ultrasound
- Single intrauterine pregnancy
- Planned for termination due to missed miscarriage
You likely can't join if
- Previous history of cesarean section
- Uterine scar due to previous procedure like myomectomy
The study team makes the final eligibility decision.
Where it's taking place
- Multan, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Multan, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.